Intellia Therapeutics
NTLA
NTLA
260 hedge funds and large institutions have $5.06B invested in Intellia Therapeutics in 2021 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 110 increasing their positions, 60 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
33% more call options, than puts
Call options by funds: $108M | Put options by funds: $81M
8% more funds holding
Funds holding: 240 → 260 (+20)
11.2% less ownership
Funds ownership: 104.5% → 93.31% (-11%)
Holders
260
Holding in Top 10
7
Calls
$108M
Puts
$81M
Top Buyers
| 1 | +$136M | |
| 2 | +$79.3M | |
| 3 | +$54.5M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$52.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$39.2M |
Top Sellers
| 1 | -$127M | |
| 2 | -$53.9M | |
| 3 | -$40.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$33.8M |
| 5 |
State Street
Boston,
Massachusetts
|
-$33.2M |